![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CCDC15 | Human | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | EXP | | 6480464 | Dihydrotestosterone results in increased expression of CCDC15 mRNA | CTD | PMID:29581250 | CCDC15 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CCDC15 mRNA | CTD | PMID:20106945 and PMID:21632981 | CCDC15 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Ccdc15 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCDC15 mRNA | CTD | PMID:33387578 | CCDC15 | Human | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of CCDC15 mRNA | CTD | PMID:30851411 | CCDC15 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of CCDC15 mRNA | CTD | PMID:21179406 | CCDC15 | Human | 4,4'-sulfonyldiphenol | decreases expression | ISO | Ccdc15 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of CCDC15 mRNA | CTD | PMID:30951980 | CCDC15 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of CCDC15 gene | CTD | PMID:27153756 | CCDC15 | Human | amphetamine | decreases expression | ISO | Ccdc15 (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of CCDC15 mRNA | CTD | PMID:30779732 | CCDC15 | Human | azathioprine | decreases expression | EXP | | 6480464 | Azathioprine results in decreased expression of CCDC15 mRNA | CTD | PMID:22623647 | CCDC15 | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CCDC15 mRNA | CTD | PMID:32234424 | CCDC15 | Human | bisphenol A | increases expression | ISO | Ccdc15 (Mus musculus) | 6480464 | bisphenol A results in increased expression of CCDC15 mRNA | CTD | PMID:26063408 | CCDC15 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CCDC15 mRNA | CTD | PMID:29275510 | CCDC15 | Human | bisphenol A | affects expression | ISO | Ccdc15 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of CCDC15 mRNA | CTD | PMID:25181051 | CCDC15 | Human | bisphenol F | decreases expression | ISO | Ccdc15 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of CCDC15 mRNA | CTD | PMID:30951980 | CCDC15 | Human | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of CCDC15 mRNA | CTD | PMID:21592394 | CCDC15 | Human | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CCDC15 mRNA | CTD | PMID:21592394 | CCDC15 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CCDC15 gene] | CTD | PMID:28238834 | CCDC15 | Human | chlorpyrifos | decreases expression | ISO | Ccdc15 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of CCDC15 mRNA | CTD | PMID:37019170 | CCDC15 | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of CCDC15 mRNA | CTD | PMID:27594783 | CCDC15 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of CCDC15 mRNA | CTD | PMID:19549813 | CCDC15 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CCDC15 mRNA | CTD | PMID:20106945 more ... | CCDC15 | Human | cytarabine | increases expression | EXP | | 6480464 | Cytarabine results in increased expression of CCDC15 mRNA | CTD | PMID:21198554 | CCDC15 | Human | epoxiconazole | increases expression | ISO | Ccdc15 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of CCDC15 mRNA | CTD | PMID:35436446 | CCDC15 | Human | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of CCDC15 mRNA | CTD | PMID:23649840 | CCDC15 | Human | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of CCDC15 mRNA | CTD | PMID:23649840 | CCDC15 | Human | gentamycin | increases expression | ISO | Ccdc15 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of CCDC15 mRNA | CTD | PMID:33387578 | CCDC15 | Human | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of CCDC15 mRNA | CTD | PMID:28988120 | CCDC15 | Human | manganese(II) chloride | increases expression | ISO | Ccdc15 (Rattus norvegicus) | 6480464 | manganese chloride results in increased expression of CCDC15 mRNA | CTD | PMID:28801915 | CCDC15 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of CCDC15 mRNA | CTD | PMID:23649840 | CCDC15 | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of CCDC15 mRNA | CTD | PMID:28001369 | CCDC15 | Human | N-methyl-4-phenylpyridinium | increases expression | ISO | Ccdc15 (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of CCDC15 mRNA | CTD | PMID:28801915 | CCDC15 | Human | paracetamol | increases expression | ISO | Ccdc15 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of CCDC15 mRNA | CTD | PMID:33387578 | CCDC15 | Human | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of CCDC15 mRNA | CTD | PMID:22714537 | CCDC15 | Human | propanal | decreases expression | EXP | | 6480464 | propionaldehyde results in decreased expression of CCDC15 mRNA | CTD | PMID:26079696 | CCDC15 | Human | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of CCDC15 mRNA | CTD | PMID:21632981 | CCDC15 | Human | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of CCDC15 mRNA | CTD | PMID:30851411 | CCDC15 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of CCDC15 mRNA | CTD | PMID:23557933 | CCDC15 | Human | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CCDC15 mRNA | CTD | PMID:21592394 | CCDC15 | Human | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of CCDC15 mRNA | CTD | PMID:21592394 | CCDC15 | Human | titanium dioxide | decreases methylation | ISO | Ccdc15 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of CCDC15 gene | CTD | PMID:35295148 | CCDC15 | Human | titanium dioxide | increases methylation | ISO | Ccdc15 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of CCDC15 promoter | CTD | PMID:35295148 | CCDC15 | Human | trichloroethene | increases expression | ISO | Ccdc15 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of CCDC15 mRNA | CTD | PMID:33387578 | CCDC15 | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of CCDC15 mRNA | CTD | PMID:24935251 | CCDC15 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of CCDC15 mRNA | CTD | PMID:37042841 | CCDC15 | Human | Triptolide | increases expression | ISO | Ccdc15 (Mus musculus) | 6480464 | triptolide results in increased expression of CCDC15 mRNA | CTD | PMID:32835833 | CCDC15 | Human | triptonide | affects expression | ISO | Ccdc15 (Mus musculus) | 6480464 | triptonide affects the expression of CCDC15 mRNA | CTD | PMID:33045310 | CCDC15 | Human | trovafloxacin | decreases expression | ISO | Ccdc15 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of CCDC15 mRNA | CTD | PMID:35537566 | CCDC15 | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of CCDC15 mRNA | CTD | PMID:28818685 | CCDC15 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CCDC15 mRNA | CTD | PMID:23527032 | CCDC15 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of CCDC15 mRNA | CTD | PMID:25979313 | CCDC15 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of CCDC15 mRNA | CTD | PMID:23179753 and PMID:24935251 | CCDC15 | Human | vorinostat | increases expression | EXP | | 6480464 | vorinostat results in increased expression of CCDC15 mRNA | CTD | PMID:27188386 | |